Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis.

ABSTRACT:

Background

Multiple sclerosis is an inflammatory and degenerative disease of the central nervous system (CNS) characterized by demyelination and concomitant axonal loss. The lack of a single specific test, and the similarity to other inflammatory diseases of the central nervous system, makes it difficult to have a clear diagnosis of multiple sclerosis. Therefore, laboratory tests that allows a clear and definite diagnosis, as well as to predict the different clinical courses of the disease are of utmost importance. Herein, we compared the cerebrospinal fluid (CSF) proteome of patients with multiple sclerosis (in the relapse-remitting phase of the disease) and other diseases of the CNS (inflammatory and non-inflammatory) aiming at identifying reliable biomarkers of multiple sclerosi

SUBMITTER: Salazar IL 

PROVIDER: S-EPMC8822857 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature